BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36438697)

  • 1. E3 ubiquitin ligase
    Li WW; Yuan H; Kong S; Tian SB
    World J Gastrointest Oncol; 2022 Nov; 14(11):2183-2194. PubMed ID: 36438697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
    Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
    J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
    Zuo X; Cai J; Chen Z; Li Y; Zhang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Tripartite Motif Conaining 55 (TRIM55) Inhibits Migration and Invasion of Hepatocellular Carcinoma (HCC) Cells via Epithelial-Mesenchymal Transition and Matrix Metalloproteinase-2 (MMP2).
    Li X; Huang L; Gao W
    Med Sci Monit; 2019 Jan; 25():771-777. PubMed ID: 30685767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
    Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
    World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition.
    Zhang D; Wu P; Zhang Z; An W; Zhang C; Pan S; Tan Y; Xu H
    Pathol Res Pract; 2020 Aug; 216(8):153002. PubMed ID: 32703484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-box and leucine-rich repeat 6 promotes gastric cancer progression
    Meng L; Hu YT; Xu AM
    World J Gastrointest Oncol; 2023 Mar; 15(3):490-503. PubMed ID: 37009323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPEB4 promotes growth and metastasis of gastric cancer cells via ZEB1-mediated epithelial- mesenchymal transition.
    Cao G; Chen D; Liu G; Pan Y; Liu Q
    Onco Targets Ther; 2018; 11():6153-6165. PubMed ID: 30288051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPV4 Overexpression Promotes Metastasis Through Epithelial-Mesenchymal Transition in Gastric Cancer and Correlates with Poor Prognosis.
    Wang H; Zhang B; Wang X; Mao J; Li W; Sun Y; Yuan Y; Ben Q; Hua L; Qian A
    Onco Targets Ther; 2020; 13():8383-8394. PubMed ID: 32943876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.
    Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D
    J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM37 promotes cell invasion and metastasis by regulating SIP1-mediated epithelial-mesenchymal transition in gastric cancer.
    Chen D; You X; Pan Y; Liu Q; Cao G
    Onco Targets Ther; 2018; 11():8803-8813. PubMed ID: 30573971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA CCDC66 promotes gastric cancer progression by regulating c-Myc and TGF-β signaling pathways.
    Xu G; Chen Y; Fu M; Zang X; Cang M; Niu Y; Zhang W; Zhang Y; Mao Z; Shao M; Qian H; Xu W; Cai H; Jiang P; Zhang X
    J Cancer; 2020; 11(10):2759-2768. PubMed ID: 32226494
    [No Abstract]   [Full Text] [Related]  

  • 14. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.
    Xie R; Wang X; Qi G; Wu Z; Wei R; Li P; Zhang D
    Tumour Biol; 2016 Sep; 37(9):12049-12059. PubMed ID: 27179963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer.
    Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW
    World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX5 promotes cell invasion and metastasis via activation of Twist-mediated epithelial-mesenchymal transition in gastric cancer.
    You J; Zhao Q; Fan X; Wang J
    Onco Targets Ther; 2019; 12():2465-2476. PubMed ID: 31040690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
    Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
    Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial-Mesenchymal Transition In Gastric Cancer.
    Li T; Deng L; He X; Jiang G; Hu F; Ye S; You Y; Duanmu J; Dai H; Huang G; Tang C; Lei X
    Cancer Manag Res; 2019; 11():9353-9369. PubMed ID: 31807065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer.
    Liu H; Zhao YR; Chen B; Ge Z; Huang JS
    Cancer Manag Res; 2019; 11():3493-3509. PubMed ID: 31118775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.